April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Evaluation of a Novel Contact Lens for Treating Binocular Diplopia
Author Affiliations & Notes
  • Matthieu P. Robert
    Service d'Ophtalmologie, Hôpital Necker-Enfants Malades, Paris, France
    Department of Medicine, Imperial College, London, United Kingdom
  • Fabrizio Bonci
    Department of Medicine, Imperial College, London, United Kingdom
  • Anand Pandit
    Department of Medicine, Imperial College, London, United Kingdom
  • Veronica Ferguson
    Department of Medicine, Imperial College, London, United Kingdom
  • Parashkev Nachev
    Department of Medicine, Imperial College, London, United Kingdom
    Institute of Neurology, UCL, London, United Kingdom
  • Footnotes
    Commercial Relationships  Matthieu P. Robert, GB Patent n°0715309.1, International Patent n°WO 2009/019451,EU Patent n° US Patent n°20100265458 (P); Fabrizio Bonci, None; Anand Pandit, None; Veronica Ferguson, None; Parashkev Nachev, GB Patent n°0715309.1, International Patent n°WO 2009/019451,EU Patent n° US Patent n°20100265458 (P)
  • Footnotes
    Support  Imperial Innovations/Johnson & Johnson Proof of Concept Fund at Imperial College London
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3902. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Matthieu P. Robert, Fabrizio Bonci, Anand Pandit, Veronica Ferguson, Parashkev Nachev; Evaluation of a Novel Contact Lens for Treating Binocular Diplopia. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3902.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Monocular occlusion is currently the reference method to symptomatically treat binocular diplopia (BD). In some pathological conditions however, monocular central scotomata with preserved peripheral visual field have been shown to abolish BD. Here we evaluate a novel contact lens that abolishes BD by changing the spatial visual acuity in one eye to approximate the inverse of the spatial acuity function across the retina. The performance of the device is compared with conventional eye patching in normal subjects and in patients with BD.

Methods: : The normal cohort included 12 subjects with normal vision in whom full field 10° of vertical BD was induced using Fresnel lenses. The patient cohort included 12 patients with BD of diverse causes. Comparisons were made during reading, room navigation, self-examination and distance viewing, using a structured questionnaire with scores ranging from 1 (worst) to 10 (perfect). Estermann perimetry was also performed in the normal cohort. The distributions of responses were compared using paired Kolmogorov-Smirnov two sample tests with mean scores and asymptotic p values.

Results: : In the normal cohort, the two methods were equally effective in abolishing BD (patch (P) 8.42, lens (L) 8.75, p=0.991) and in comfort (P 6.50, L 6.17, p=0.990), but the lens was rated superior in aesthetics (P 2.33, L 8.75, p<0.001) and overall (P 6.42, L 8.67, p=0.005). Performance on Estermann perimetry was superior with the lens (P 14.92 missed locations, L 0.92 missed locations, p<0.001). In the patient cohort, both methods were identically effective in abolishing BD (P 9.73, L 9.27, p=0.985), but the lens was superior on other measures: aesthetics (P 2, L 9.45, p<0.001), comfort (P 4.36, L 7.45, p=0.047) and overall (P 4.18, L 8.54, p<0.001).

Conclusions: : This novel device offers an effective method to abolish BD, while being superior to conventional patching in terms of visual field preservation, aesthetics comfort and overall effectiveness.

Keywords: visual impairment: neuro-ophthalmological disease • neuro-ophthalmology: cortical function/rehabilitation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×